Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Patent
1995-06-07
1998-03-17
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
514709, 424 10, A61K 31095, A61K 3110, A61K 4900
Patent
active
057287384
ABSTRACT:
Injectable mesna solutions having a pH value higher than 7.5. The solutions have increased storage stability.
REFERENCES:
patent: 4720379 (1988-01-01), Heyl et al.
Corn et al., "Bioavailability of subcutaneous Ifosfamide and feasibility of continuous outpatient application in cancer patients", Anals of Oncology, vol. 1, pp. 365-368, 1990.
Kwon et al., "Activation Mechanisms of Mafosfamide and the Role of Thiols in Cyclophosphamide Metabolism", J. Med. Chem. 1987, vol. 30, pp. 395-399.
Leeuwenkamp, et al., "Reaction Kinetics of Cisplatin and its Monoaquated Species with the Modulating Agents (Di)mesna and Thiosulphate", Eur. J. Cancer, vol. 27, No. 10, pp. 1243-1247, 1991.
Camuglia Giancarlo
Deger Wolfgang
Engel Jurgen
Sauerbier Dieter
Wolf-Heuss Elisabeth
Asta Medica Aktiengesellschaft
Criares Theodore J.
LandOfFree
Injectable mesna solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable mesna solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable mesna solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-958128